Feb 3 (Reuters) - GlaxoSmithKline (GSK.L) is hoping to pick up some talented scientists in its own backyard following plans by U.S. rival Pfizer (PFE.N) to shutter its research centre at Sandwich, southern England.
Feb 3 (Reuters) - GlaxoSmithKline (GSK.L) is hoping to pick up some talented scientists in its own backyard following plans by U.S. rival Pfizer (PFE.N) to shutter its research centre at Sandwich, southern England.
